{"title":"Effective Reduction of Anti-PEG Antibody Recognition via PEG Copolymers with Ethyl Glycidyl Ether and Isopropyl Glycidyl Ether","authors":"Verena Müller, Julian Schmidt, Rebecca Matthes, Philip Dreier, Sandra Schüttner, Matthias Bros, Holger Frey","doi":"10.1021/acs.biomac.6c01182","DOIUrl":null,"url":null,"abstract":"<div><div>Anti-PEG antibodies (APAs) lead to accelerated blood clearance of PEGylated drugs and nanocarriers. Randomized PEG (rPEG) reduces APA recognition by randomly incorporating glycidyl methyl ether in PEG. Extending this concept, statistical copolymerization of ethylene oxide with ethyl glycidyl ether (EGE) or isopropyl glycidyl ether (<em>i</em>PGE) was investigated. Copolymers of EO with 13–28 mol % EGE or 6–20 mol % <em>i</em>PGE showed low dispersity (<em>Đ</em> ≤ 1.09). Via online-NMR monitoring, reactivity ratios in DMSO were <em>r</em> <sub>EO</sub> = 1.39 and <em>r</em> <sub>EGE</sub> = 0.72 for P(EO-<em>co</em>-EGE) and <em>r</em> <sub>EO</sub> = 1.35 and <em>r</em> <sub> <em>i</em>PGE</sub> = 0.74 for P(EO-<em>co-i</em>PGE). All copolymers were soluble in PBS buffer at physiological temperatures and noncytotoxic, except for 20% <em>i</em>PGE content, shown by cell viability and immunostimulatory effects on murine splenocytes. All copolymers exhibit significantly reduced APA recognition (ELISA) with stronger effects for the sterically demanding <em>i</em>PGE. The findings highlight mP(EO-<em>co</em>-EGE) and mP(EO-<em>co-i</em>PGE) as promising PEG alternatives for nanomedicine and bioconjugation.</div></div><div>Anti-PEG antibodies (APAs) lead to accelerated blood clearance of PEGylated drugs and nanocarriers. Randomized PEG (rPEG) reduces APA recognition by randomly incorporating glycidyl methyl ether in PEG. Extending this concept, statistical copolymerization of ethylene oxide with ethyl glycidyl ether (EGE) or isopropyl glycidyl ether (<em>i</em>PGE) was investigated. Copolymers of EO with 13–28 mol % EGE or 6–20 mol % <em>i</em>PGE showed low dispersity (<em>Đ</em> ≤ 1.09). Via online-NMR monitoring, reactivity ratios in DMSO were <em>r</em> <sub>EO</sub> = 1.39 and <em>r</em> <sub>EGE</sub> = 0.72 for P(EO-<em>co</em>-EGE) and <em>r</em> <sub>EO</sub> = 1.35 and <em>r</em> <sub> <em>i</em>PGE</sub> = 0.74 for P(EO-<em>co-i</em>PGE). All copolymers were soluble in PBS buffer at physiological temperatures and noncytotoxic, except for 20% <em>i</em>PGE content, shown by cell viability and immunostimulatory effects on murine splenocytes. All copolymers exhibit significantly reduced APA recognition (ELISA) with stronger effects for the sterically demanding <em>i</em>PGE. The findings highlight mP(EO-<em>co</em>-EGE) and mP(EO-<em>co-i</em>PGE) as promising PEG alternatives for nanomedicine and bioconjugation.</div><div><div><span><figure><span><img><ol><li><span><span>Download: <span>Download high-res image (43KB)</span></span></span></li><li><span><span>Download: <span>Download full-size image</span></span></span></li></ol></span></figure></span></div></div><div><span><figure><span><img><ol><li><span><span>Download: <span>Download high-res image (43KB)</span></span></span></li><li><span><span>Download: <span>Download full-size image</span></span></span></li></ol></span></figure></span></div>","PeriodicalId":30,"journal":{"name":"Biomacromolecules","volume":"27 9","pages":"Pages 6165-6174"},"PeriodicalIF":5.9000,"publicationDate":"2026-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomacromolecules","FirstCategoryId":"92","ListUrlMain":"https://www.sciencedirect.com/org/science/article/pii/S1525779726003727","RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/12 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Anti-PEG antibodies (APAs) lead to accelerated blood clearance of PEGylated drugs and nanocarriers. Randomized PEG (rPEG) reduces APA recognition by randomly incorporating glycidyl methyl ether in PEG. Extending this concept, statistical copolymerization of ethylene oxide with ethyl glycidyl ether (EGE) or isopropyl glycidyl ether (iPGE) was investigated. Copolymers of EO with 13–28 mol % EGE or 6–20 mol % iPGE showed low dispersity (Đ ≤ 1.09). Via online-NMR monitoring, reactivity ratios in DMSO were rEO = 1.39 and rEGE = 0.72 for P(EO-co-EGE) and rEO = 1.35 and riPGE = 0.74 for P(EO-co-iPGE). All copolymers were soluble in PBS buffer at physiological temperatures and noncytotoxic, except for 20% iPGE content, shown by cell viability and immunostimulatory effects on murine splenocytes. All copolymers exhibit significantly reduced APA recognition (ELISA) with stronger effects for the sterically demanding iPGE. The findings highlight mP(EO-co-EGE) and mP(EO-co-iPGE) as promising PEG alternatives for nanomedicine and bioconjugation.
Anti-PEG antibodies (APAs) lead to accelerated blood clearance of PEGylated drugs and nanocarriers. Randomized PEG (rPEG) reduces APA recognition by randomly incorporating glycidyl methyl ether in PEG. Extending this concept, statistical copolymerization of ethylene oxide with ethyl glycidyl ether (EGE) or isopropyl glycidyl ether (iPGE) was investigated. Copolymers of EO with 13–28 mol % EGE or 6–20 mol % iPGE showed low dispersity (Đ ≤ 1.09). Via online-NMR monitoring, reactivity ratios in DMSO were rEO = 1.39 and rEGE = 0.72 for P(EO-co-EGE) and rEO = 1.35 and riPGE = 0.74 for P(EO-co-iPGE). All copolymers were soluble in PBS buffer at physiological temperatures and noncytotoxic, except for 20% iPGE content, shown by cell viability and immunostimulatory effects on murine splenocytes. All copolymers exhibit significantly reduced APA recognition (ELISA) with stronger effects for the sterically demanding iPGE. The findings highlight mP(EO-co-EGE) and mP(EO-co-iPGE) as promising PEG alternatives for nanomedicine and bioconjugation.
期刊介绍:
Biomacromolecules is a leading forum for the dissemination of cutting-edge research at the interface of polymer science and biology. Submissions to Biomacromolecules should contain strong elements of innovation in terms of macromolecular design, synthesis and characterization, or in the application of polymer materials to biology and medicine.
Topics covered by Biomacromolecules include, but are not exclusively limited to: sustainable polymers, polymers based on natural and renewable resources, degradable polymers, polymer conjugates, polymeric drugs, polymers in biocatalysis, biomacromolecular assembly, biomimetic polymers, polymer-biomineral hybrids, biomimetic-polymer processing, polymer recycling, bioactive polymer surfaces, original polymer design for biomedical applications such as immunotherapy, drug delivery, gene delivery, antimicrobial applications, diagnostic imaging and biosensing, polymers in tissue engineering and regenerative medicine, polymeric scaffolds and hydrogels for cell culture and delivery.